Anaheim-based medical device maker ClearFlow Inc. secured Food and Drug Administration approval for the FlowGlide Active Clearance Technology System, a device that clears chest tubes to prevent or reduce retention of blood and fluids.
Drainage-related complications can be harmful in cardiothoracic surgery, resulting in post-surgery complications, such as retained blood syndrome.
ClearFlow develops and manufactures devices that help drain blood and fluids.
